PCF TACTICAL (Therapy ACceleration To Intercept CAncer Lethality) Awards provide up to $10 million over three years to support large-scale research projects led by qualified teams of academic scientists that specifically address the development of 21st Century therapies for lethal forms of prostate cancer.
PCF Research Awards Notification: Sign up here to be notified as research RFA’s become available.